Contact this trialFirst, we need to learn more about you.
Anti-metabolites
Tislelizumab + Chemotherapy for Gastric Cancer
Recruiting2 awardsPhase 3
Nashville, Tennessee
This trial is testing a new treatment that combines an immune-boosting drug called tislelizumab with standard chemotherapy. It targets patients with advanced stomach cancer that cannot be removed by surgery and has spread to other parts of the body. The treatment works by helping the immune system find and destroy cancer cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service